{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:40:10Z","timestamp":1782380410368,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jcrc.2021.11.004","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T13:36:21Z","timestamp":1637242581000},"page":"166-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: The MAVERIC study"],"prefix":"10.1016","volume":"67","author":[{"given":"Rahul","family":"Costa-Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ti","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Yanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Udy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.jcrc.2021.11.004_bb0005","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","author":"Peake","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcrc.2021.11.004_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jcrc.2021.11.004_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-198938050-00004","article-title":"Midodrine","volume":"38","author":"McTavish","year":"1989","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jcrc.2021.11.004_bb0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1986.101","article-title":"Pharmacodynamics of midodrine, an antihypotensive agent","volume":"39","author":"Zachariah","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jcrc.2021.11.004_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/107424840501000109","article-title":"Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy","volume":"10","author":"Sharma","year":"2005","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jcrc.2021.11.004_bb0030","doi-asserted-by":"crossref","first-page":"224A","DOI":"10.1378\/chest.1990326","article-title":"Safety of oral midodrine as a method of weaning from intravenous vasoactive medication in the medical intensive care unit","volume":"146","author":"Cardenas-Garcia","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jcrc.2021.11.004_bb0035","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jcrc.2013.05.021","article-title":"Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions","volume":"28","author":"Levine","year":"2013","journal-title":"J Crit Care"},{"issue":"3","key":"10.1016\/j.jcrc.2021.11.004_bb0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jcpt.12375","article-title":"Midodrine for the weaning of vasopressor infusions","volume":"41","author":"Poveromo","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.jcrc.2021.11.004_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.ccm.0000528219.66628.6d","article-title":"200: impact of oral midodrine on duration of intravenous vasopressor therapy","volume":"46","author":"Roach","year":"2018","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2021.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.chest.2016.02.657","article-title":"Feasibility, utility, and safety of midodrine during recovery phase from septic shock","volume":"149","author":"Whitson","year":"2016","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.jcrc.2021.11.004_bb0055","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00134-020-06216-x","article-title":"Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial","volume":"46","author":"Santer","year":"2020","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.jcrc.2021.11.004_bb0060","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1177\/0885066619843279","article-title":"Midodrine as an adjuvant to intravenous vasopressor agents in adults with resolving shock: systematic review and meta-analysis","volume":"35","author":"Hammond","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2021.11.004_bb0065","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1097\/CCM.0000000000003121","article-title":"Trends in use of midodrine in the ICU","volume":"46","author":"Rizvi","year":"2018","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2021.11.004_bb0070","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1016\/j.jcrc.2021.11.004_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00134-005-2607-3","article-title":"Norepinephrine and metaraminol in septic shock: a comparison of the hemodynamic effects","volume":"31","author":"Natalini","year":"2005","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2021.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jcrc.2021.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1572-0241.2008.01787.x","article-title":"Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study","volume":"103","author":"Singh","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jcrc.2021.11.004_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1074248408317709","article-title":"Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting","volume":"13","author":"Sharma","year":"2008","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jcrc.2021.11.004_bb0095","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S0265021502251352","article-title":"Midodrine, an alternative to intravenous vasopressor therapy after spinal surgery","volume":"19","author":"O\u2019Donnell","year":"2002","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"10.1016\/j.jcrc.2021.11.004_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-020-00737-w","article-title":"Potential risks in using midodrine for persistent hypotension after cardiac surgery: a comparative cohort study","volume":"10","author":"Tremblay","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1016\/j.jcrc.2021.11.004_bb0105","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/TP.0000000000001113","article-title":"Pretransplant midodrine use: a newly identified risk marker for complications after kidney transplantation","volume":"100","author":"Alhamad","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jcrc.2021.11.004_bb0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000494806","article-title":"The impact of midodrine on outcomes in patients with intradialytic hypotension","volume":"48","author":"Brunelli","year":"2018","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1016\/j.jcrc.2021.11.004_bb0115","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1097\/CCM.0000000000003814","article-title":"Continuation of newly initiated midodrine therapy after intensive care and hospital discharge: a single-center retrospective study","volume":"47","author":"Rizvi","year":"2019","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2021.11.004_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12871-017-0339-x","article-title":"Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial)","volume":"17","author":"Anstey","year":"2017","journal-title":"BMC Anesthesiol"},{"issue":"11","key":"10.1016\/j.jcrc.2021.11.004_bb0125","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11606-013-2520-3","article-title":"Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Parsaik","year":"2013","journal-title":"J Gen Intern Med"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944121002513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944121002513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:50:20Z","timestamp":1760125820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944121002513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":25,"alternative-id":["S0883944121002513"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2021.11.004","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: The MAVERIC study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}